Geode Capital Management LLC Raises Holdings in Zoetis Inc. $ZTS

Geode Capital Management LLC increased its position in Zoetis Inc. (NYSE:ZTS) by 0.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,081,301 shares of the company’s stock after acquiring an additional 95,294 shares during the period. Geode Capital Management LLC owned approximately 2.50% of Zoetis worth $1,721,356,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Maple Capital Management Inc. lifted its position in shares of Zoetis by 1.9% in the second quarter. Maple Capital Management Inc. now owns 87,552 shares of the company’s stock valued at $13,654,000 after acquiring an additional 1,634 shares in the last quarter. ABC Arbitrage SA acquired a new position in Zoetis during the second quarter worth $2,244,000. Accredited Investors Inc. grew its holdings in Zoetis by 35.3% in the 2nd quarter. Accredited Investors Inc. now owns 4,118 shares of the company’s stock valued at $642,000 after buying an additional 1,074 shares in the last quarter. M&G PLC grew its holdings in Zoetis by 26.7% in the 2nd quarter. M&G PLC now owns 116,174 shares of the company’s stock valued at $18,123,000 after buying an additional 24,461 shares in the last quarter. Finally, Forsta AP Fonden increased its stake in shares of Zoetis by 23.1% in the 2nd quarter. Forsta AP Fonden now owns 183,100 shares of the company’s stock worth $28,554,000 after acquiring an additional 34,300 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the subject of several analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Stifel Nicolaus set a $140.00 target price on shares of Zoetis in a report on Tuesday, November 4th. BTIG Research lowered their price target on Zoetis from $200.00 to $160.00 and set a “buy” rating for the company in a research report on Wednesday. Leerink Partners downgraded Zoetis from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Finally, UBS Group lowered their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $180.00.

Zoetis Trading Up 1.0%

Shares of Zoetis stock opened at $121.30 on Thursday. Zoetis Inc. has a 52-week low of $117.26 and a 52-week high of $181.85. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The firm has a market cap of $53.45 billion, a price-to-earnings ratio of 20.88, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company’s 50-day simple moving average is $142.21 and its 200-day simple moving average is $151.94.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the prior year, the firm posted $1.58 EPS. The company’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio is presently 33.67%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.